AC
ITOS

AXQ Capital’s iTeos Therapeutics ITOS Stock Holding History

AXQ Capital’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,860
Closed -$138K – 705
2025
Q2 		$138K Buy
+13,860
New +$112K 0.04% 493

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AXQ Capital's ITOS Position: Q3 2025 in Review

AXQ Capital sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 13,860 shares — an estimated $138K sold.

AXQ Capital first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $138K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • AXQ Capital reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • AXQ Capital sold 13,860 iTeos Therapeutics shares in Q3 2025, an estimated $138K.
  • AXQ Capital first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
  • AXQ Capital's iTeos Therapeutics position peaked at $138K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on AXQ Capital's 13F filing for Q3 2025, filed 10 Nov 2025.